come from Israel, the only country in the world that has vaccinated over a third of its population (which is about 9 million), thanks to an "excellent organization on the one hand and, apparently, an agreement with Pfizer -BioNTech on the other. It seems, in fact, that the Government has accepted to provide a series of articulated and complex data on vaccinations in a constant manner, useful for carrying out further analyzes on the vaccine, in exchange for other supplies. About a month after " start of the vaccination campaign, which started on 19 December, most of the vaccinated have received the first dose, while the rest have already completed the two-dose course.
: about a week after the second dose, however, the effectiveness rises to 95%. At the moment it is known that the drug protects against Covid-19, preventing the symptoms of the disease from developing. It has not yet been clarified, however, whether make the vaccinated person less contagious.
. In fact, in most cases the tests to find any positivity were carried out on people who were already symptomatic.
The survey also took into account the number of hospitalized and people with severe symptoms. In the week of December 26 to January 2 and January 2 to January 9, the number of individuals with severe symptoms had increased by 30% in each week. In the week of January 9-16, however, the increase was only 7%. The reason? Probably the fact that in early January 40% of Israel's over 60s had been vaccinated. A "hypothesis that seems supported also by what happened instead in the age group between 40 and 55 years, in which the vaccinated subjects are still few: in this case, in fact, cases with severe symptoms have increased by 20-30 % in each of the three weeks.
For the elderly unable to move, in some Italian regions it will be possible to take advantage of the Vaccini Covid-19 service at home.
severe, which has certainly contributed to reducing new infections. According to estimates, it will take several weeks to see the first real effects of the Covid-19 vaccine. Among other things, the situation is now becoming more complicated, also due to the new variants, which seem to be particularly aggressive in the Middle Eastern country.
Especially in the larger countries, such as Italy (which has 60 million inhabitants, 7 times those of Israel), it will take a few more months to observe the effect of vaccines, among other things, always hoping that the vaccination campaigns will continue as This is not at all obvious considering that there have already been the first setbacks, such as the slowdown in supplies of Pfizer-BioNTech to many European countries, due to some activities to strengthen its production site in Belgium.
